August 2017

Considerations in Response to Drug-Drug Interaction Guidances

Author:  Michael Millhollen
Posted:  17 August 2017

Check out the recent IQ consortium publication: Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on Down-regulation, CYP2C Induction and CYP2B6 Positive Control, which was published in Drug Metabolism and Disposition and included data generated at Sekisui XenoTech utilizing our attaching human hepatocytes...

Read more

Comments
Blog post currently doesn't have any comments.
Give Feedback